Hajissa Khalid, Mutiat Hammed-Akanmu, Kaabi Nawal Al, Alissa Mohammed, Garout Mohammed, Alenezy Anood A, Almaghrabi Rana H, Alrasheed Hayam A, Al-Subaie Maha F, Alhani Hatem M, Alshehri Ahmad A, Almazni Ibrahim Abdullah, Alqahtani Ali S, Bahwerth Fayez Saeed, Alqethami Nourah Hashem, Alzayer Amal A, Rabaan Ali A
Department of Zoology, Faculty of Science and Technology, Omdurman Islamic University, Omdurman 14415, Sudan.
Department of Biomedicine, School of Health Sciences, Universiti Sains Malaysia, Kubang Kerian 16150, Kelantan, Malaysia.
Vaccines (Basel). 2023 Jun 6;11(6):1070. doi: 10.3390/vaccines11061070.
Despite the effectiveness of current vaccines in reducing the spread and severity of SARS-CoV-2 infections, many people, including migrants, refugees, and foreign workers, are hesitant to be vaccinated. This systematic review and meta-analysis (SRMA) was conducted to determine the pooled prevalence estimate of the acceptance and hesitancy rates of the COVID-19 vaccine among these populations. A comprehensive search of the peer-reviewed literature indexed in PubMed, Scopus, Science Direct, and Web of Science databases was conducted. Initially, 797 potential records were identified, of which 19 articles met the inclusion criteria. A meta-analysis of proportions using data from 14 studies revealed that the overall acceptance rate of COVID vaccination among 29,152 subjects was 56.7% (95% CI: 44.9-68.5%), while the prevalence of vaccine hesitancy among 26,154 migrants reported in 12 studies was estimated to be 31.7% (95% CI: 44.9-68.5%). The acceptance rate for the COVID-19 vaccination first declined from 77.3% in 2020 to 52.9% in 2021 and then slightly increased to 56.1% in 2022. The most frequent factors influencing vaccine hesitancy were worries about vaccine efficacy and safety. Intensive vaccination campaigns should be implemented to raise vaccination awareness among migrants, which will increase the acceptance rate for the COVID-19 vaccine and result in herd immunity.
尽管当前疫苗在降低新冠病毒感染的传播和严重程度方面具有有效性，但包括移民、难民和外籍工人在内的许多人对接种疫苗仍持犹豫态度。开展这项系统评价和荟萃分析（SRMA）以确定这些人群中新冠疫苗接受率和犹豫率的合并患病率估计值。对PubMed、Scopus、Science Direct和Web of Science数据库中索引的同行评审文献进行了全面检索。最初识别出797条潜在记录，其中19篇文章符合纳入标准。对14项研究的数据进行的比例荟萃分析显示，29,152名受试者中新冠疫苗的总体接受率为56.7%（95%置信区间：44.9 - 68.5%），而12项研究报告的26,154名移民中疫苗犹豫的患病率估计为31.7%（95%置信区间：44.9 - 68.5%）。新冠疫苗接种的接受率首先从2020年的77.3%下降到2021年的52.9%，然后在2022年略有上升至56.1%。影响疫苗犹豫的最常见因素是对疫苗效力和安全性的担忧。应开展强化疫苗接种运动以提高移民中的疫苗接种意识，这将提高新冠疫苗的接受率并实现群体免疫。
